Trial site
Hangzhou Seventh People's Hospital
Hangzhou, Zhejiang 310003, ChinaNot linked to an institution yet
The trials here
What the 7 trials at this site are about, from their registry records.
- Phase
- Phase 35 trials
- Phase 22 trials
- Lead sponsor
- Biohaven Pharmaceuticals, Inc.1 trial
- Ignis Therapeutics (Suzhou) Limited1 trial
- Jiangsu Nhwa Pharmaceutical Co., Ltd.1 trial
- Jiangsu Simcere Pharmaceutical Co., Ltd.1 trial
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company1 trial
- and 2 more
Closed trials
Completed
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior
NCT07193901· Phase 2· Sichuan Purity Pharmaceutical Technology Co., Ltd.· Source
Completed
A Phase II Study to Evaluate NH102 for Depression
NCT06842992· Phase 2· Jiangsu Nhwa Pharmaceutical Co., Ltd.· Source
Completed
Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive Disorder
NCT07253207· Phase 3· Zhejiang Huahai Pharmaceutical Co., Ltd.· Source
Completed
A Study of Daridorexant in Chinese Patients With Insomnia Disorder
NCT06010693· Phase 3· Jiangsu Simcere Pharmaceutical Co., Ltd.· Source
Completed
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients with Obstructive Sleep Apnea (OSA)
NCT06103825· Phase 3· Ignis Therapeutics (Suzhou) Limited· Source
Completed
A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia
NCT05919823· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source
Completed
A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder
NCT04693351· Phase 3· Biohaven Pharmaceuticals, Inc.· Source
Report an error